Stockscreener 앱 받기
5.60
6.35%
-0.38
시간 외 거래:
5.62
0.02
+0.36%
Novavax Inc 주식(NVAX)의 최신 뉴스
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS - Yahoo Finance
Novavax’s Covid vaccine delayed in FDA review - The Business Journals
Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst - Benzinga
FDA delays full approval of Novavax COVID-19 vaccine even though it was on track for clearance - KHBS
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED) - Benzinga
Novavax (NVAX) Stock Climbs Amid FDA Approval Delay for COVID-19 Vaccine - GuruFocus
Sanofi-Novavax deal in jeopardy as FDA halts vaccine approval - Bizcommunity
US Drug Regulator Delays Novavax Covid Vaccine Approval - Barron's
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why - Nasdaq
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance - KTVZ
US FDA misses deadline for decision on Novavax's COVID-19 vaccine - Reuters
Novavax Can Confirm That April 1, Was U.S FDA'S PDUFA Date For BLA Seeking Approval Of Our Covid-19 Vaccine - MarketScreener
Novavax set to snap six days of losses as shares trade in green - MSN
Novavax awaits FDA decision on COVID-19 vaccine BLA - Investing.com India
Novavax (NVAX) COVID-19 Vaccine Approval Delayed by FDA - GuruFocus
Novavax awaits FDA decision on COVID-19 vaccine BLA By Investing.com - Investing.com UK
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine - Benzinga
Novavax (NasdaqGS:NVAX) Sees 21% Weekly Drop As Leadership Changes Shake Market - Yahoo Finance
Exclusive | FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official - WSJ
Novavax bid for full approval of COVID vaccine stymied by FDA - Seeking Alpha
FDA misses deadline for decision on Novavax's COVID-19 vaccine, WSJ reports - TradingView
FDA Misses Deadline For Covid-19 Vaccine Decision, Novavax's Application Needed More Data- WSJ - MarketScreener
The Market Doesn't Like What It Sees From Novavax, Inc.'s (NASDAQ:NVAX) Revenues Yet As Shares Tumble 28% - simplywall.st
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out - WSJ
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Top vaccine official’s ouster sends biotech stocks tumbling - The Boston Globe
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief - MarketScreener
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ - Yahoo Finance
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies' - Fortune
Moderna, Novavax Drop After FDA’s Top Vaccine Official Exits - Bloomberg.com
Biopharma, Biotech stocks tumble on FDA shakeup - Investing.com India
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
FDA official’s ouster sends shares of vaccine makers sliding - Yahoo Finance
Novavax seeks authorization of updated COVID shot in Europe - MSN
Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com Australia
Where are the Opportunities in (NVAX) - Stock Traders Daily
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
The industry heavyweight behind Novavax’s push to bounce back - PharmaVoice
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
Ebola Vaccine Market Generated Opportunities, Future Scope - openPR
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
(NVAX) Technical Pivots with Risk Controls - Stock Traders Daily
1.23%
1.63%
자본화:
|
볼륨(24시간):